江湖电竞数据统计手机版

BOSTON (江湖电竞最新版比赛(江湖电竞投注app网站)) -- A federal judge on Wednesday upheld the Obama Administration's decision to restore federal funding for certain types of embryonic stem-cell research, according to reports. A U.S. District Court in Washington, D.C., ruled that funds offered for such research through the National Institutes of Health do not violate federal law. Shares of three stem-cell research companies moved higher following the news, including Advanced Cell Technology actc , BioTime Inc. BTIM, , and International Stem Cell Corp. ISCO, -3.93% .